文献速递肝病

人群对代谢功能障碍相关脂肪性肝病筛查获益与危害的看法

Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease.
PubMed 文献 · Hepatology · 2025-03-18

该研究向2020至2024年明尼苏达州奥姆斯特德县一项前瞻性MASLD筛查研究的参与者发放问卷,评估筛查后的焦虑、污名、生活质量、偏好筛查方式、经济顾虑和生活方式影响。461名参与者中342人(74%)完成调查。结论认为主动筛查MASLD的感知获益超过危害,强调通过以患者为中心的方案进行早期筛查的重要性。

要点

  • 14%的参与者报告筛查相关焦虑,14%担心向他人披露可能的MASLD诊断。
  • 无MASLD诊断者中99%对肝脏健康感到安心,48%报告生活质量改善,25%改变了饮食、饮酒和体力活动。
  • 确诊MASLD的77名参与者中52%对新诊断有一定焦虑,但95%和97%分别认为早期诊断对降低肝硬化和心血管疾病风险重要。

核心结论

  • 这项基于人群的调查表明,主动筛查MASLD的感知获益(如提高认识、改变生活方式和早期诊断)超过危害。
  • 这些发现强调通过以患者为中心的方案进行早期筛查以改善健康结局的重要性。

研究设计与样本

  • 向2020至2024年明尼苏达州奥姆斯特德县一项前瞻性MASLD筛查研究的参与者发放调查问卷。
  • 问卷评估筛查和诊断后参与者的焦虑、污名、生活质量、偏好筛查方式、经济顾虑和生活方式影响。
  • 461名参与者中342人(74%)完成调查。

主要发现

  • 14%的参与者报告筛查相关焦虑,14%担心向他人披露可能的MASLD诊断。
  • 无MASLD诊断者中99%对肝脏健康感到安心,48%报告生活质量改善,25%改变了饮食、饮酒和体力活动。
  • 确诊MASLD的77名参与者中52%对新诊断有一定焦虑;95%认为早期MASLD诊断对降低肝硬化风险重要,97%认为对降低心血管疾病风险重要。
  • 确诊参与者中79%认为诊断有助于采取更健康习惯,30%在筛查后实现超过10%的体重下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Screening for diseases can have psychological impacts, such as anxiety, and requires acceptability from the population to be effective. This study examined the perspectives on the benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease (MASLD) among the general population to optimize screening practices. APPROACH AND RESULTS: A survey was sent to participants enrolled between 2020 and 2024 in a prospective MASLD screening study in Olmsted County, MN. The survey assessed participants' perceived anxiety, stigma, quality of life, preferred screening methods, financial concerns, and lifestyle impacts following screening and diagnosis. Of the 461 participants, 342 (74%) completed the survey. Overall, 14% of participants reported screening-related anxiety, and 14% were concerned about disclosing a potential MASLD diagnosis to others. Among those without a MASLD diagnosis, 99% felt reassured about their liver health, 48% reported an improved quality of life, and 25% made lifestyle changes pertaining to their diet, alcohol use, and physical activity. Of the 77 participants diagnosed with MASLD, 52% experienced some anxiety about their new diagnosis; however, 95% and 97% considered it important to receive an early MASLD diagnosis to mitigate the risk for cirrhosis and cardiovascular disease, respectively. Notably, 79% of diagnosed participants found the diagnosis beneficial in adopting healthier habits, with 30% achieving a >10% weight loss after screening. CONCLUSION: This population-based survey demonstrates that the perceived benefits of proactive MASLD screening, such as increased awareness, lifestyle changes, and early diagnosis, outweigh the harms. These findings highlight the importance of early screening through patient-centered protocols to improve health outcomes.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Allen AM, Kim WR, Carrieri P, et al. Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease. Hepatology. 2025. PMID: 40105977. doi:10.1097/HEP.0000000000001311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。